APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor XI

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Coagulation Factor XI Market Outlook and Growth Opportunities 2026

Report ID 173979050419 December 2025191 pages

Choose your research edition.

Industry ResearchCoagulation Factor XI Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor XI Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Coagulation Factor XI Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor XI Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor XI Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Coagulation Factor XI market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Coagulation Factor XI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coagulation Factor XI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coagulation Factor XI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Coagulation Factor XI market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Coagulation Factor XI market include Bristol-Myers Squibb Company, Cambryn Biologics LLC, eXithera Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc., LegoChem Biosciences, Inc and Bayer AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Coagulation Factor XI market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coagulation Factor XI and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coagulation Factor XI revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Coagulation Factor XI market.

Coagulation Factor XI Segment by Company

Bristol-Myers Squibb Company

Cambryn Biologics LLC

eXithera Pharmaceuticals, Inc

Ionis Pharmaceuticals, Inc.

LegoChem Biosciences, Inc

Bayer AG

Coagulation Factor XI Segment by Type

MR-1007

IONIS-FXIRx

EP-7041

BMS-262084

AB-022

Others

Coagulation Factor XI Segment by Application

Thrombosis

Acute Ischemic Stroke

Bleeding and Clotting Disorders

Others

Coagulation Factor XI Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Coagulation Factor XI status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Coagulation Factor XI key companies, revenue, market share, and recent developments.

3. To split the Coagulation Factor XI breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Coagulation Factor XI market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Coagulation Factor XI significant trends, drivers, influence factors in global and regions.

6. To analyze Coagulation Factor XI competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor XI market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor XI and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor XI.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coagulation Factor XI industry.

Chapter 3: Detailed analysis of Coagulation Factor XI company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Coagulation Factor XI in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Coagulation Factor XI in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Coagulation Factor XI Industry Trends Table 2. Coagulation Factor XI Industry Drivers Table 3. Coagulation Factor XI Industry Opportunities and Challenges Table 4. Coagulation Factor XI Industry Restraints Table 5. Global Coagulation Factor XI Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Coagulation Factor XI Revenue Share by Company (2021-2026) Table 7. Global Coagulation Factor XI Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Coagulation Factor XI Key Company Manufacturing Base & Headquarters Table 9. Global Coagulation Factor XI Company, Product Type & Application Table 10. Global Coagulation Factor XI Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Coagulation Factor XI by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of MR-1007 Table 15. Significant Companies of IONIS-FXIRx Table 16. Significant Companies of EP-7041 Table 17. Significant Companies of BMS-262084 Table 18. Significant Companies of AB-022 Table 19. Significant Companies of Others Table 20. Global Coagulation Factor XI Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Coagulation Factor XI Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Coagulation Factor XI Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Coagulation Factor XI Sales Value Share by Type (2021-2026) Table 24. Global Coagulation Factor XI Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Thrombosis Table 26. Significant Companies of Acute Ischemic Stroke Table 27. Significant Companies of Bleeding and Clotting Disorders Table 28. Significant Companies of Others Table 29. Global Coagulation Factor XI Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Coagulation Factor XI Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Coagulation Factor XI Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Coagulation Factor XI Sales Value Share by Application (2021-2026) Table 33. Global Coagulation Factor XI Sales Value Share by Application (2027-2032) Table 34. Global Coagulation Factor XI Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Coagulation Factor XI Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Coagulation Factor XI Sales Value Share by Region (2021-2026) Table 37. Global Coagulation Factor XI Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Coagulation Factor XI Sales Value Share by Region (2027-2032) Table 39. Global Coagulation Factor XI Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Coagulation Factor XI Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Coagulation Factor XI Sales Value Market Share by Country (2021-2026) Table 42. Global Coagulation Factor XI Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Coagulation Factor XI Sales Value Market Share by Country (2027-2032) Table 44. Bristol-Myers Squibb Company Company Information Table 45. Bristol-Myers Squibb Company Business Overview Table 46. Bristol-Myers Squibb Company Coagulation Factor XI Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Bristol-Myers Squibb Company Coagulation Factor XI Product Portfolio Table 48. Bristol-Myers Squibb Company Recent Development Table 49. Cambryn Biologics LLC Company Information Table 50. Cambryn Biologics LLC Business Overview Table 51. Cambryn Biologics LLC Coagulation Factor XI Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Cambryn Biologics LLC Coagulation Factor XI Product Portfolio Table 53. Cambryn Biologics LLC Recent Development Table 54. eXithera Pharmaceuticals, Inc Company Information Table 55. eXithera Pharmaceuticals, Inc Business Overview Table 56. eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Portfolio Table 58. eXithera Pharmaceuticals, Inc Recent Development Table 59. Ionis Pharmaceuticals, Inc. Company Information Table 60. Ionis Pharmaceuticals, Inc. Business Overview Table 61. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Portfolio Table 63. Ionis Pharmaceuticals, Inc. Recent Development Table 64. LegoChem Biosciences, Inc Company Information Table 65. LegoChem Biosciences, Inc Business Overview Table 66. LegoChem Biosciences, Inc Coagulation Factor XI Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. LegoChem Biosciences, Inc Coagulation Factor XI Product Portfolio Table 68. LegoChem Biosciences, Inc Recent Development Table 69. Bayer AG Company Information Table 70. Bayer AG Business Overview Table 71. Bayer AG Coagulation Factor XI Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bayer AG Coagulation Factor XI Product Portfolio Table 73. Bayer AG Recent Development Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Coagulation Factor XI Product Image Figure 2. Global Coagulation Factor XI Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 4. Global Coagulation Factor XI Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. MR-1007 Image Figure 8. IONIS-FXIRx Image Figure 9. EP-7041 Image Figure 10. BMS-262084 Image Figure 11. AB-022 Image Figure 12. Others Image Figure 13. Global Coagulation Factor XI Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Coagulation Factor XI Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Coagulation Factor XI Sales Value Share by Type (2021-2032) Figure 16. Thrombosis Image Figure 17. Acute Ischemic Stroke Image Figure 18. Bleeding and Clotting Disorders Image Figure 19. Others Image Figure 20. Global Coagulation Factor XI Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Coagulation Factor XI Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Coagulation Factor XI Sales Value Share by Application (2021-2032) Figure 23. Global Coagulation Factor XI Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Coagulation Factor XI Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Coagulation Factor XI Sales Value (2021-2032) & (US$ Million) Figure 26. North America Coagulation Factor XI Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Coagulation Factor XI Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Coagulation Factor XI Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Coagulation Factor XI Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Coagulation Factor XI Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Coagulation Factor XI Sales Value (2021-2032) & (US$ Million) Figure 32. South America Coagulation Factor XI Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Coagulation Factor XI Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Coagulation Factor XI Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Coagulation Factor XI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • MR-1007
  • IONIS-FXIRx
  • EP-7041
  • BMS-262084
  • AB-022
  • Others
Applications
  • Thrombosis
  • Acute Ischemic Stroke
  • Bleeding and Clotting Disorders
  • Others
Companies covered
  • Bristol-Myers Squibb Company
  • Cambryn Biologics LLC
  • eXithera Pharmaceuticals, Inc
  • Ionis Pharmaceuticals, Inc.
  • LegoChem Biosciences, Inc
  • Bayer AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Coagulation Factor XI Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Coagulation Factor XI Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Coagulation Factor XI Market Dynamics
  1. 2.1 Coagulation Factor XI Industry Trends
  2. 2.2 Coagulation Factor XI Industry Drivers
  3. 2.3 Coagulation Factor XI Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor XI Industry Restraints
3 Coagulation Factor XI Market by Company
  1. 3.1 Global Coagulation Factor XI Company Revenue Ranking in 2025
  2. 3.2 Global Coagulation Factor XI Revenue by Company (2021-2026)
  3. 3.3 Global Coagulation Factor XI Company Ranking (2024-2026)
  4. 3.4 Global Coagulation Factor XI Company Manufacturing Base and Headquarters
  5. 3.5 Global Coagulation Factor XI Company Product Type and Application
  6. 3.6 Global Coagulation Factor XI Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Coagulation Factor XI Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Coagulation Factor XI Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Coagulation Factor XI Market by Type
  1. 4.1 Coagulation Factor XI Type Introduction
  2. 4.1.1 MR-1007
  3. 4.1.2 IONIS-FXIRx
  4. 4.1.3 EP-7041
  5. 4.1.4 BMS-262084
  6. 4.1.5 AB-022
  7. 4.1.6 Others
  8. 4.2 Global Coagulation Factor XI Sales Value by Type
  9. 4.2.1 Global Coagulation Factor XI Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Coagulation Factor XI Sales Value by Type (2021-2032)
  11. 4.2.3 Global Coagulation Factor XI Sales Value Share by Type (2021-2032)
5 Coagulation Factor XI Market by Application
  1. 5.1 Coagulation Factor XI Application Introduction
  2. 5.1.1 Thrombosis
  3. 5.1.2 Acute Ischemic Stroke
  4. 5.1.3 Bleeding and Clotting Disorders
  5. 5.1.4 Others
  6. 5.2 Global Coagulation Factor XI Sales Value by Application
  7. 5.2.1 Global Coagulation Factor XI Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Coagulation Factor XI Sales Value by Application (2021-2032)
  9. 5.2.3 Global Coagulation Factor XI Sales Value Share by Application (2021-2032)
6 Coagulation Factor XI Regional Value Analysis
  1. 6.1 Global Coagulation Factor XI Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coagulation Factor XI Sales Value by Region (2021-2032)
  3. 6.2.1 Global Coagulation Factor XI Sales Value by Region: 2021-2026
  4. 6.2.2 Global Coagulation Factor XI Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Coagulation Factor XI Sales Value (2021-2032)
  7. 6.3.2 North America Coagulation Factor XI Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Coagulation Factor XI Sales Value (2021-2032)
  10. 6.4.2 Europe Coagulation Factor XI Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Coagulation Factor XI Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Coagulation Factor XI Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Coagulation Factor XI Sales Value (2021-2032)
  16. 6.6.2 South America Coagulation Factor XI Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Coagulation Factor XI Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Coagulation Factor XI Sales Value Share by Country, 2025 VS 2032
7 Coagulation Factor XI Country-level Value Analysis
  1. 7.1 Global Coagulation Factor XI Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Coagulation Factor XI Sales Value by Country (2021-2032)
  3. 7.2.1 Global Coagulation Factor XI Sales Value by Country (2021-2026)
  4. 7.2.2 Global Coagulation Factor XI Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Coagulation Factor XI Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Coagulation Factor XI Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Coagulation Factor XI Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bristol-Myers Squibb Company
  2. 8.1.1 Bristol-Myers Squibb Company Company Information
  3. 8.1.2 Bristol-Myers Squibb Company Business Overview
  4. 8.1.3 Bristol-Myers Squibb Company Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bristol-Myers Squibb Company Coagulation Factor XI Product Portfolio
  6. 8.1.5 Bristol-Myers Squibb Company Recent Developments
  7. 8.2 Cambryn Biologics LLC
  8. 8.2.1 Cambryn Biologics LLC Company Information
  9. 8.2.2 Cambryn Biologics LLC Business Overview
  10. 8.2.3 Cambryn Biologics LLC Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cambryn Biologics LLC Coagulation Factor XI Product Portfolio
  12. 8.2.5 Cambryn Biologics LLC Recent Developments
  13. 8.3 eXithera Pharmaceuticals, Inc
  14. 8.3.1 eXithera Pharmaceuticals, Inc Company Information
  15. 8.3.2 eXithera Pharmaceuticals, Inc Business Overview
  16. 8.3.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  17. 8.3.4 eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Portfolio
  18. 8.3.5 eXithera Pharmaceuticals, Inc Recent Developments
  19. 8.4 Ionis Pharmaceuticals, Inc.
  20. 8.4.1 Ionis Pharmaceuticals, Inc. Company Information
  21. 8.4.2 Ionis Pharmaceuticals, Inc. Business Overview
  22. 8.4.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Portfolio
  24. 8.4.5 Ionis Pharmaceuticals, Inc. Recent Developments
  25. 8.5 LegoChem Biosciences, Inc
  26. 8.5.1 LegoChem Biosciences, Inc Company Information
  27. 8.5.2 LegoChem Biosciences, Inc Business Overview
  28. 8.5.3 LegoChem Biosciences, Inc Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  29. 8.5.4 LegoChem Biosciences, Inc Coagulation Factor XI Product Portfolio
  30. 8.5.5 LegoChem Biosciences, Inc Recent Developments
  31. 8.6 Bayer AG
  32. 8.6.1 Bayer AG Company Information
  33. 8.6.2 Bayer AG Business Overview
  34. 8.6.3 Bayer AG Coagulation Factor XI Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer AG Coagulation Factor XI Product Portfolio
  36. 8.6.5 Bayer AG Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst